These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8348031)

  • 41. [Mechanism of the anti-arrhythmic action of phosphocreatine in acute myocardial ischemia].
    Rozenshtraukh LV; Saks VA; Aniukhovskiĭ EP; Beloshapko GG; Iushmanova Av
    Kardiologiia; 1985 Apr; 25(4):80-5. PubMed ID: 4021280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. "Time-course of the effect of intravenously administered phosphocreatine on ATP and CP concentrations in rat heart".
    Borgoglio R; Piacenza G; Osella R
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):253-6. PubMed ID: 9704118
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of treatment with trimethazidine on characteristics of arrhythmia and indicators of heart rhythm in patients with chronic cardiac failure].
    Nesterova IV; Kutuzova AE; Sveshnikov IuG; Sitnikova MIu; Nedoshivin AO
    Ter Arkh; 2003; 75(3):61-4. PubMed ID: 12718225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Cardioprotective, inotropic, and anti-arrhythmia properties of a complex adaptogen "Tonizid"].
    Lishmanov IuB; Maslov LN; Arbuzov AG; Krylatov AV; Platonov AA; Burkova VN; Kaiumova EA
    Eksp Klin Farmakol; 2008; 71(3):15-22. PubMed ID: 18652250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Heart arrhythmias and congestive heart failure].
    Abuladze GV; Narciia EV; Mamamtavrishvili ND; Nikolaishvili MG; Kantariia DA
    Georgian Med News; 2006 Apr; (133):41-4. PubMed ID: 16705224
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of 711389-S, a new antiarrhythmic agent, on myocardial energy metabolism in guinea-pigs and rats.
    Iwaki K; Ishii M; Shinosaki T; Ueda M; Yonetani Y
    J Pharm Pharmacol; 1988 Jan; 40(1):10-6. PubMed ID: 2896767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization.
    Prabhakar G; Vona-Davis L; Murray D; Lakhani P; Murray G
    J Am Coll Surg; 2003 Nov; 197(5):786-91. PubMed ID: 14585415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The anti-arrhythmic activity of agonists of the peripheral mu-opiate receptors].
    Maslov LN; Krylatov AV; Lishmanov IuB
    Eksp Klin Farmakol; 1999; 62(3):28-31. PubMed ID: 10439944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
    Gao S; Long CL; Wang RH; Wang H
    Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Myocardial substrate metabolism in the normal and failing heart.
    Stanley WC; Recchia FA; Lopaschuk GD
    Physiol Rev; 2005 Jul; 85(3):1093-129. PubMed ID: 15987803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart.
    Ceconi C; Cargnoni A; Francolini G; Parinello G; Ferrari R
    Cardiovasc Res; 2009 Oct; 84(1):72-82. PubMed ID: 19477966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
    Mulder P; Barbier S; Chagraoui A; Richard V; Henry JP; Lallemand F; Renet S; Lerebours G; Mahlberg-Gaudin F; Thuillez C
    Circulation; 2004 Apr; 109(13):1674-9. PubMed ID: 14981003
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of acute heart failure.
    Webb AR
    Minerva Anestesiol; 2002 Apr; 68(4):196-200. PubMed ID: 12024082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Creatine phosphate as a drug in acute myocardial infarct].
    Komárek J; Strnadová V
    Cas Lek Cesk; 1992 Apr; 131(8):248-9. PubMed ID: 1638616
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Heart energy metabolism and its role in the treatment of heart failure].
    Castro P; Gabrielli L; Verdejo H; Greig D; Mellado R; Concepción R; Sepúlveda L; Vukasovic JL; García L; Pizarro M; Pivet D; Carrillo C; Tapia F; Navarro M; Troncoso R; Baraona F; Llevaneras S; Hernández C; Godoy I; Jalil JE; Quintana JC; Orellana P; Chiong M; Lavandero S
    Rev Med Chil; 2010 Aug; 138(8):1028-39. PubMed ID: 21140063
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Comparative characteristics of the experimental antifibrillatory action of anti-arrhythmia preparations].
    Storozhuk BG; Stoliarchuk AA
    Farmakol Toksikol; 1980; 43(5):579-81. PubMed ID: 7449988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The effect of benzohexonium on myocardial metabolic processes in the presence of neurogenic heart pathology].
    Novikova NA; Isachenko VB; Kovaleva VA
    Farmakol Toksikol; 1975; 38(1):48-9. PubMed ID: 234397
    [No Abstract]   [Full Text] [Related]  

  • 58. [Anti-arrhythmic action of a carbon tetrafluoride emulsion].
    Afonin NI; Alabovskiĭ VV; Doronina NN
    Biull Eksp Biol Med; 1982 Jul; 94(7):60-1. PubMed ID: 7126831
    [No Abstract]   [Full Text] [Related]  

  • 59. [Protective action of guanosine-5'-monophosphate in circulatory insufficiency due to the administration of adrenaline].
    Luk'ianova IIu; Eliseev VV
    Anesteziol Reanimatol; 1987; (5):19-21. PubMed ID: 2829659
    [No Abstract]   [Full Text] [Related]  

  • 60. [The Ca2+ reactivity and the subunit composition of myocardial actomyosin during the pyromecaine and pyrroxan treatment of experimental ischemia].
    Kaĭfadzhian MA; Dzhanpoladian EG
    Farmakol Toksikol; 1990; 53(1):27-30. PubMed ID: 1970309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.